Jacqueline Claire Lupo
Chief Executive Officer bij LOPHOS HOLDINGS INC.
Vermogen: 660 000 $ op 30-04-2024
Profiel
Jacqueline Claire Lupo is the founder of Lophos Pharmaceuticals Corp., where she holds the title of President, CEO & Director since 2021.
She is also the founder of Canalytica Corp.
Ms. Lupo's current job is as the Chief Executive Officer & Director at Lophos Holdings, Inc. since 2021.
Additionally, she is currently working as a Manager at Northern Green Canada, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LOPHOS HOLDINGS, INC.
14.90% | 12-02-2024 | 11 000 000 ( 14.90% ) | 660 000 $ | 30-04-2024 |
Actieve functies van Jacqueline Claire Lupo
| Bedrijven | Functie | Begin |
|---|---|---|
| LOPHOS HOLDINGS INC. | Chief Executive Officer | 23-12-2021 |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The private company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Founder | 01-01-2021 |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - |
Eerdere bekende functies van Jacqueline Claire Lupo
| Bedrijven | Functie | Einde |
|---|---|---|
| Canalytica Corp. | Founder | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
| Northern Green Canada, Inc. | Consumer Non-Durables |
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The private company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Lophos Holdings, Inc. | |
| Canalytica Corp. |
